SCHEMBL8993499

SCHEMBL8993499

O=C(O)[C@@]1(c2ccccc2)O[C@@H]1c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.38
AKR1C1 Q04828 1/20 0.37
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
CYP3A4 P08684 1/20 0.35
ALOX15 P16050 1/20 0.35
EPHX1 P07099 1/20 0.35
HSD11B1 P28845 4/20 0.34
CHRM2 P08172 2/20 0.34
CHRM4 P08173 2/20 0.34
CHRM5 P08912 2/20 0.34
CHRM1 P11229 2/20 0.34
CHRM3 P20309 2/20 0.34
EDNRA P25101 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ALDH1A1 P00352 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8108217 1.00 PTGS2 (0.38) PTGS2AKR1C1LMNAHTTCYP3A4
SCHEMBL9257647 1.00 PTGS2 (0.38) PTGS2AKR1C1LMNAHTTCYP3A4
SCHEMBL4529008 0.84 EPHX1 (0.40) PTGS2LMNACYP3A4ALOX15EPHX1
SCHEMBL14968177 0.81 CYP3A4 (0.51) HTTCYP3A4ALOX15KMT2ANPSR1
SCHEMBL14968090 0.80 ALDH1A1 (0.40) PTGS2HTTCYP3A4ALOX15KMT2A
SCHEMBL17599624 0.78 EDNRA (0.42) LMNAHSD11B1EDNRAKMT2AALDH1A1
SCHEMBL14967286 0.77 RORC (0.39) HTTCYP3A4ALOX15CHRM2CHRM4
SCHEMBL14967798 0.77 TSHR (0.47) HTTKMT2AALDH1A1L3MBTL1
SCHEMBL14967663 0.77 CHRM3 (0.41) PTGS2LMNAHTTCYP3A4ALOX15
SCHEMBL14968092 0.77 CYP3A4 (0.38) LMNAHTTCYP3A4ALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5574169-A CHOLECYSTOKININ ANTAGONIST ELI LILLY AND COMPANY (US) 1996-11-12 US disclosed
US-5399708-A Cholecystokinin and gastrin antagonists; gastrointestinal and central nervous system disorders ELI LILLY AND COMPANY (US) 1995-03-21 US disclosed